Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation Between Quantitative Pupillometry and Other Markers for Neuroprognostication of Comatose Patients After Cardiac Arrest: A Bicentric Study.

Critical care medicine·2026
Same author

Status Epilepticus Is Detected Earlier than Seizures on cEEG in Critically Ill Adults.

Neurocritical care·2026
Same author

Effects of midazolam and propofol on EEG detection of epileptiform activity in patients with altered consciousness.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring.

Critical care medicine·2026
Same author

Brainstem Respiratory Center Dysfunction in Persons With Epilepsy: An fMRI Study.

Neurology·2026
Same author

Relevance of EEG recording time for juvenile myoclonic epilepsy diagnosis confirmation: a reappraisal.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026

Related Experiment Video

Updated: May 19, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Treatment deviating from guidelines does not influence status epilepticus prognosis.

Andrea O Rossetti1, Vincent Alvarez, Jean-Marie Januel

  • 1Service de Neurologie, CHUV, BH-07, 1011 Lausanne, Switzerland. andrea.rossetti@chuv.ch

Journal of Neurology
|August 18, 2012
PubMed
Summary

Treatment adherence to guidelines for status epilepticus (SE) did not significantly impact patient outcomes. Prognosis is primarily linked to nonmodifiable factors like etiology and SE severity, not adherence to current drug protocols.

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Related Experiment Videos

Last Updated: May 19, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Area of Science:

  • Neurology
  • Clinical Medicine
  • Pharmacology

Background:

  • Prognosis in status epilepticus (SE) is influenced by nonmodifiable factors, but the role of drug treatment remains unclear.
  • Assessing treatment adherence to guidelines (TAG) is crucial for understanding SE outcomes.
  • Existing research lacks clarity on whether adhering to current SE treatment protocols affects patient prognosis.

Purpose of the Study:

  • To investigate the prognostic role of treatment adherence to guidelines (TAG) in adult patients with incident status epilepticus (SE).
  • To determine if TAG impacts mortality and return to baseline conditions after SE.
  • To adjust prognostic analyses for established factors like etiology, SE severity, and comorbidities.

Main Methods:

  • Prospective study of 225 adult patients with incident SE over 26 months (excluding postanoxic cases).
  • TAG assessed based on drug dosage (±30% of recommendations) and medication sequence.
  • Outcomes (mortality, return to baseline) analyzed using logistic regression and ROC curves, adjusted for etiology, SE severity (STESS), and comorbidities.

Main Results:

  • Treatment adherence to guidelines (TAG) was observed in 63% of patients.
  • TAG was not associated with mortality, return to baseline, or SE control on univariate or logistic regression analyses.
  • Etiology and SE severity score (STESS ≥ 3) were independent predictors of mortality and poor return to baseline.

Conclusions:

  • Current treatment adherence to guidelines for status epilepticus appears to have a negligible prognostic role.
  • The biological background, including etiology and SE severity, remains the most significant factor influencing SE outcomes.
  • Further research and trials are needed to identify novel therapeutic approaches for improving SE prognosis.